MSB 3.13% 99.0¢ mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-208

  1. 7,820 Posts.
    lightbulb Created with Sketch. 1344
    Believe what you want. Phaedrus typed a lot but honestly didn't say much.

    I backed up my statements with citations.

    Do your own reading. Had you read any of those papers before making your decisions? Have you read them since? If so that's good, this is your investment. You absolutely should.

    We will see who ends up being correct in the end. MEB may have something significant but it is ages away from commercialisation, and I wouldn't invest at this stage, not even for a cheeky punt.

    I've been right about the things I've been attacked for over the last year on this board, for the most part. Maybe I'm wrong this time.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.030(3.13%)
Mkt cap ! $1.130B
Open High Low Value Volume
96.5¢ $1.03 96.5¢ $4.704M 4.708M

Buyers (Bids)

No. Vol. Price($)
6 87395 98.5¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 274051 2
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.